Iovance Biotherapeutics, Inc. demonstrates improved Q4 results, with $87M revenue and a 50% gross margin. Learn more about IOVA stock here.
Audiences will be entertained when the dark, surreal comedy, “Mr. Marmalade,” brings humor and heavy topics to SUNY Cortland this week. The play, written by Noah Haidle, explores the imaginative world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results